Ipratropium bromide: Pregnancy category B. Studies have demonstrated no teratogenic effects as a result of Ipratropium.
Salbutamol: Pregnancy category C. Salbutamol has been shown to be teratogenic in animals. There are, however no adequate and well-controlled studies of Salbutamol + Ipratropium bromide (i-BREATH PLUS) Metered Dose Inhaler (Salbutamol and Ipratropium bromide combination) in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk of the fetus. It is not known whether the components of the Salbutamol + Ipratropium bromide (i-BREATH PLUS) Inhalation Aerosol are excreted in human milk. As many drugs are excreted in human milk, Salbutamol + Ipratropium bromide (i- BREATH PLUS) should be cautiously administered to a nursing mother.